多模式纳米结构生物气凝的最新进展,用于智能药物输送
Muhanad A Abdulsamad1, Lujin A Essa2, Rabia Alghazeer3
1Department of Zoology, Faculty of Science, Sabratha University, Sabratha 00218, Libya.
Polymers
|November 27, 2025
概括
多模纳米结构生物气凝结合了纳米技术和生物气凝,用于先进的智能药物输送. 这些材料提供传感,定位和治疗作用,提高效率并实现实时监控.
科学领域:
- 生物材料科学 生物材料科学
- 纳米技术纳米技术
- 药物输送系统 药物输送系统
背景情况:
- 纳米技术和生物气凝正在融合,以创造先进的多模式纳米结构生物气凝.
- 这些材料提供集成的传感,准和治疗功能,以增强药物输送.
- 它们旨在提高药物的疗效,减少副作用,并允许实时监测.
研究的目的:
- 提供多模纳米结构生物气凝的全面审查.
- 分析它们的结构设计,性能和制造.
- 探索它们在响应式药物输送和精准医学中的应用.
主要方法:
- 关于多式纳米结构生物气凝的现有文献的审查.
- 对结构设计,物理化学性质和制造策略的分析.
- 检查刺激反应机制和纳米材料的结合.
主要成果:
- 多模生物气凝通过内置的纳米材料表现出可调节的多孔性和可控的药物释放.
- 刺激反应机制 (pH,温度,酶) 允许有针对性和按需释放药物.
- 精准医学中的应用包括癌症治疗,抗菌治疗和组织工程.
结论:
- 多模纳米结构生物气凝代表了下一代智能药物递送的变革潜力.
- 需要进一步的研究来解决临床翻译的可扩展性,生物相容性和监管合规性方面的挑战.
- 跨学科的合作是推动这些生物气凝向临床应用的关键.
相关概念视频
Drug Delivery: Overview
705
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
705
Drug Delivery: Miscellaneous Routes
697
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
697
Bioavailability Enhancement: Drug Permeability Enhancement
176
Body:After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt...
176
Drug Delivery: Enteral Route
1.5K
The enteral drug administration involves three primary routes: oral, sublingual, and buccal. Oral ingestion is the most prevalent, safe, economical, and convenient method for drug administration. However, it has certain drawbacks, including limited absorption due to the drug's low water solubility or poor membrane permeability, possible emesis from GI mucosa irritation, destruction of drugs by digestive enzymes or low gastric pH, and irregular absorption along with food or other drugs.
1.5K
Drug Delivery: Parenteral Route
1.5K
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
1.5K
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
185
Body:Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
185


